Wedbush Has Optimistic Outlook of KNSA Q1 Earnings
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Research analysts at Wedbush increased their Q1 2025 earnings per share (EPS) estimates for Kiniksa Pharmaceuticals in a report released on Tuesday, February 25th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of $0.31 for the quarter, up from their prior […]
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA – Free Report) – Research analysts at Wedbush increased their Q1 2025 earnings per share (EPS) estimates for Kiniksa Pharmaceuticals in a report released on Tuesday, February 25th. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings per share of $0.31 for the quarter, up from their prior […]
